Parkinson’s News Forums › Forums › Parkinson’s Research › Potential Parkinson’s Treatment, DNS201, Safe and Well-Tolerated in Phase 1 Study, Denali Says

  • Parkinson’s Research

    Potential Parkinson’s Treatment, DNS201, Safe and Well-Tolerated in Phase 1 Study, Denali Says

    Posted by Forum Moderator on August 8, 2018 at 5:53 pm

    Denali Therapeutics’ reports that DNL201, an LRRK2 inhibitor, was seen to be safe in healthy people and may advance into a trial in Parkinson’s patients.

    Read more abuot this study here.

    What do you think about this news?

    replied 5 years, 9 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .